semaglutide fda approval approves obesity drug that helped people cut weight 15% Novo Nordisk's Ozempic® pill, the

Without proper myelin, nerves get damaged, leading to tingling, numbness, and pain

Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024

Whether youre looking to lose 10 pounds or over 100, we have an option designed for you

3C), showed exceptionally high antigen loads (Fig

rather than addressing a line here or a fold there, treat the patient from the inside out for true rejuvenation

Choosing between Ozempic and Tirzepatide depends on your individual health profile, weight loss goals, and medical history